PharmaTher Holdings (PHRM.CN) launched Personaliz3D Peptides, a new division to develop and commerci

As the Canadian market navigates through a period of uncertainty, marked by fluctuating energy supplies and geopolitical tensions, investors are keenly observing how these factors might influence future growth trajectories. Amidst this backdrop, penny stocks—despite their somewhat outdated label—continue to capture attention for their potential to offer value and growth opportunities at lower entry points. This article explores several promising penny stocks on the TSX that stand out for...

The Canadian market is experiencing a mix of optimism and caution, with recent job growth surprising to the upside and AI-related enthusiasm driving both innovation and volatility. Amid this backdrop, penny stocks—typically smaller or newer companies—remain an intriguing investment area despite being considered somewhat outdated. When these stocks are supported by strong financial health, they can offer unique opportunities for growth at lower price points.

PharmaTher Holdings (PHRM.CN), up 10% on last look, Thursday confirmed that the sale of its Abbrevia

PharmaTher Holdings (PHRM.CN) down 22% on last look, said Wednesday it has sold its abbreviated new

PharmaTher Holdings (PHRM.CN) was edging up Tuesday after announcing plans to bring its ketamine dru